February 28, 2026 04:48 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Panic in Kolkata! Powerful earthquake sends people fleeing buildings | Kejriwal and Sisodia acquitted in liquor policy case; AAP chief calls arrest 'Modi-Shah's conspiracy' | Pakistan bombs Kabul after Afghan forces strike border — tensions on the brink of war! | India crush Zimbabwe by 72 runs to stay alive in T20 World Cup semifinal race | 'CBFC didn't apply mind': Kerala High Court stays Kerala Story 2 release | Operation Sindoor 2.0 will be stronger if India forced to launch: Top Army commander warns Pakistan | ‘Heads must roll!’ Supreme Court cracks down on NCERT textbook over judiciary chapter | ‘1.2 crore voters may be dropped’: Mamata Banerjee flags major concern over SIR list | India-US trade deal at risk? Trump imposes massive 126% duty on solar imports | ‘My life reflects this reality’: Shooter Tara Shahdeo recalls forced conversion amid Kerala Story 2 row
Johnson Baby Powder
Image Credit: wikipedia.org

Maharashtra FDA cancels Johnson & Johnson baby powder licence

| @indiablooms | Sep 18, 2022, at 05:06 am

Mumbai: The Maharashtra FDA has cancelled the baby talcum powder manufacturing licence of Johnson & Johnson, Mulund, after the department found it "Not Of Standard Quality".

The FDA said that the licence was cancelled after samples of the Johnson’s Baby Powder collected from Nashik and Pune failed quality checks and ordered the company to recall all its stocks from the markets.

These samples were declared by the FDA as ‘Not Of Standard Quality’ after they failed to comply with IS5339:2009 (Second Revision Amendment No. 3) Specification for Skin Powder for infants in the test pH.

In a statement, the FDA said: “The product Johnsons Baby Powder is popularly used in newborn babies. The sample declared 'Not of Standard' in pH and the use of the product may affect the health of the skin of the newborn babies.”

The firm "didn't accept the report" and challenged it in court for sending it to the Central Drugs Laboratory, the FDA said, according to media reports.

(With UNI inputs)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.